2014 Q1 Form 10-Q Financial Statement
#000114420414008396 Filed on February 13, 2014
Income Statement
| Concept | 2014 Q1 | 2013 Q4 | 2012 Q4 |
|---|---|---|---|
| Revenue | $835.0K | $757.0K | $307.0K |
| YoY Change | 126.9% | 146.58% | 119.29% |
| Cost Of Revenue | $690.0K | $590.3K | $368.8K |
| YoY Change | 32.69% | 60.05% | 8.47% |
| Gross Profit | $143.0K | $167.0K | -$62.00K |
| YoY Change | -193.46% | -369.35% | -69.0% |
| Gross Profit Margin | 17.13% | 22.06% | -20.2% |
| Selling, General & Admin | $1.340M | $1.306M | $1.393M |
| YoY Change | -4.96% | -6.27% | -19.95% |
| % of Gross Profit | 937.06% | 781.77% | |
| Research & Development | $80.00K | $118.5K | $94.42K |
| YoY Change | -33.33% | 25.49% | -21.31% |
| % of Gross Profit | 55.94% | 70.95% | |
| Depreciation & Amortization | $50.00K | $51.48K | $63.18K |
| YoY Change | -37.5% | -18.53% | -29.8% |
| % of Gross Profit | 34.97% | 30.82% | |
| Operating Expenses | $1.420M | $1.424M | $1.487M |
| YoY Change | -7.19% | -4.26% | -20.46% |
| Operating Profit | -$1.274M | -$1.257M | -$1.549M |
| YoY Change | -24.21% | -18.85% | -25.17% |
| Interest Expense | -$160.0K | $31.79K | -$20.00K |
| YoY Change | 300.0% | -258.93% | 0.0% |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$10.00K | $0.00 | -$18.01K |
| YoY Change | -100.0% | ||
| Pretax Income | -$1.440M | -$1.840M | -$1.567M |
| YoY Change | -16.28% | 17.44% | -24.66% |
| Income Tax | $1.600K | $0.00 | $0.00 |
| % Of Pretax Income | |||
| Net Earnings | -$1.441M | -$1.840M | -$1.567M |
| YoY Change | -16.07% | 17.42% | -24.66% |
| Net Earnings / Revenue | -172.57% | -243.06% | -510.42% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$290.9K | -$374.0K | -$498.4K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 59.45M shares | ||
| Diluted Shares Outstanding | 65.13M shares | 37.83M shares |
Balance Sheet
| Concept | 2014 Q1 | 2013 Q4 | 2012 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $400.0K | $200.0K | $600.0K |
| YoY Change | -33.33% | -66.67% | -78.57% |
| Cash & Equivalents | $369.6K | $220.0K | $585.1K |
| Short-Term Investments | |||
| Other Short-Term Assets | $196.5K | $102.7K | $100.0K |
| YoY Change | 41.48% | 2.72% | 0.0% |
| Inventory | $29.70K | $30.01K | $100.0K |
| Prepaid Expenses | |||
| Receivables | $515.8K | $635.7K | $200.0K |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $1.112M | $988.4K | $900.0K |
| YoY Change | 16.0% | 9.82% | -70.97% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $408.9K | $464.1K | $500.0K |
| YoY Change | -19.11% | -7.18% | -28.57% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Total Long-Term Assets | $598.3K | $662.6K | $800.0K |
| YoY Change | -24.97% | -17.18% | -27.27% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $1.112M | $988.4K | $900.0K |
| Total Long-Term Assets | $598.3K | $662.6K | $800.0K |
| Total Assets | $1.710M | $1.651M | $1.700M |
| YoY Change | -2.61% | -2.88% | -59.52% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $600.0K | $900.0K | $700.0K |
| YoY Change | -33.33% | 28.57% | 0.0% |
| Accrued Expenses | $500.0K | $400.0K | $200.0K |
| YoY Change | 150.0% | 100.0% | -66.67% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $3.000M | $500.0K | $100.0K |
| YoY Change | 114.29% | 400.0% | -88.89% |
| Total Short-Term Liabilities | $4.014M | $1.774M | $1.000M |
| YoY Change | 60.74% | 77.38% | -54.55% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $1.300M | $1.300M |
| YoY Change | -100.0% | 0.0% | -7.14% |
| Other Long-Term Liabilities | |||
| YoY Change | |||
| Total Long-Term Liabilities | $0.00 | $1.300M | $1.300M |
| YoY Change | -100.0% | 0.0% | -7.14% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $4.014M | $1.774M | $1.000M |
| Total Long-Term Liabilities | $0.00 | $1.300M | $1.300M |
| Total Liabilities | $4.014M | $3.051M | $2.300M |
| YoY Change | 5.12% | 32.67% | -36.11% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$85.88M | -$84.43M | |
| YoY Change | 29.51% | ||
| Common Stock | $83.57M | $83.03M | |
| YoY Change | 30.08% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | -$2.304M | -$1.400M | -$600.0K |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $1.710M | $1.651M | $1.700M |
| YoY Change | -2.61% | -2.88% | -59.52% |
Cashflow Statement
| Concept | 2014 Q1 | 2013 Q4 | 2012 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$1.441M | -$1.840M | -$1.567M |
| YoY Change | -16.07% | 17.42% | -24.66% |
| Depreciation, Depletion And Amortization | $50.00K | $51.48K | $63.18K |
| YoY Change | -37.5% | -18.53% | -29.8% |
| Cash From Operating Activities | -$1.220M | -$840.0K | -$1.020M |
| YoY Change | 9.91% | -17.65% | -31.08% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $0.00 | $0.00 | -$20.00K |
| YoY Change | -100.0% | -100.0% | -88.24% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | |||
| YoY Change | |||
| Cash From Investing Activities | $0.00 | $0.00 | -$20.00K |
| YoY Change | -100.0% | -100.0% | -88.24% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 1.370M | 540.0K | -30.00K |
| YoY Change | 15.13% | -1900.0% | -94.12% |
| NET CHANGE | |||
| Cash From Operating Activities | -1.220M | -840.0K | -1.020M |
| Cash From Investing Activities | 0.000 | 0.000 | -20.00K |
| Cash From Financing Activities | 1.370M | 540.0K | -30.00K |
| Net Change In Cash | 150.0K | -300.0K | -1.070M |
| YoY Change | -600.0% | -71.96% | -50.46% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$1.220M | -$840.0K | -$1.020M |
| Capital Expenditures | $0.00 | $0.00 | -$20.00K |
| Free Cash Flow | -$1.220M | -$840.0K | -$1.000M |
| YoY Change | 22.0% | -16.0% | -23.66% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt"> </font></i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 24.5pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from estimated amounts. The Company’s significant estimates include allowances for doubtful accounts and sales returns, recoverability of long-lived assets, deferred taxes and their accompanying valuations, valuation of derivative liabilities and valuation of common stock, warrants and stock options issued for products, services and conversion of debt.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
| CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1773814 | USD |
| CY2013Q1 | us-gaap |
Liabilities
Liabilities
|
3819072 | USD |
| us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">Concentrations of Credit Risk</font></i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 24.5pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company maintains its cash accounts in financial institutions. Accounts at these institutions are insured by the Federal Deposit Insurance Corporation (“FDIC”) with basic deposit coverage limits up to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font> per owner. At December 31, 2013 and March 31, 2013, the Company had approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">214,000</font>, respectively, of cash balances which exceeded the FDIC insurance limit. The Company performs ongoing evaluations of these institutions to limit its concentration risk exposure.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
| cyrx |
Increased In Monthly Principal Payment
IncreasedInMonthlyPrincipalPayment
|
2500 | USD | |
| CY2013Q1 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
1321664 | USD |
| CY2013Q1 | us-gaap |
Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
|
20848 | USD |
| CY2013Q4 | us-gaap |
Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
|
3 | USD |
| CY2013Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2497408 | USD |
| CY2013Q4 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
1277546 | USD |
| CY2013Q4 | cyrx |
Maximum Amount Of Aggregate Monthly Principal Payment
MaximumAmountOfAggregateMonthlyPrincipalPayment
|
10000 | USD |
| CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
3051360 | USD |
| CY2013Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2013Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2013Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
37761 | USD |
| CY2013Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
563104 | USD |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
219970 | USD |
| CY2013Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
217097 | USD |
| CY2013Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
635687 | USD |
| CY2013Q1 | us-gaap |
Inventory Net
InventoryNet
|
39212 | USD |
| CY2013Q4 | us-gaap |
Inventory Net
InventoryNet
|
30008 | USD |
| CY2013Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
138892 | USD |
| CY2013Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
102718 | USD |
| CY2013Q1 | us-gaap |
Assets Current
AssetsCurrent
|
958305 | USD |
| CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
988383 | USD |
| CY2013Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
505485 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
464122 | USD |
| CY2013Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
272263 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
189094 | USD |
| CY2013Q1 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
19744 | USD |
| CY2013Q4 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
9358 | USD |
| CY2013Q1 | us-gaap |
Assets
Assets
|
1755797 | USD |
| CY2013Q4 | us-gaap |
Assets
Assets
|
1650957 | USD |
| CY2013Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
858709 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
895902 | USD |
| CY2013Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
217432 | USD |
| CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
391438 | USD |
| CY2013Q1 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
1304419 | USD |
| CY2013Q4 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
390471 | USD |
| CY2013Q1 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
96000 | USD |
| CY2013Q4 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
96000 | USD |
| CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
59247 | USD |
| CY2013Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
64210412 | USD |
| CY2013Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
82975314 | USD |
| CY2013Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-66311448 | USD |
| CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-84434964 | USD |
| CY2013Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2063275 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1400403 | USD |
| CY2013Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1755797 | USD |
| CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1650957 | USD |
| cyrx |
Maturity Period Of Highly Liquid Investments
MaturityPeriodOfHighlyLiquidInvestments
|
P90D | ||
| CY2013Q4 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | USD |
| CY2013Q1 | cyrx |
Cash Exceeds Fdic Insurance Limits
CashExceedsFdicInsuranceLimits
|
214000 | USD |
| CY2013Q4 | cyrx |
Cash Exceeds Fdic Insurance Limits
CashExceedsFdicInsuranceLimits
|
0 | USD |
| CY2013Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
8700 | USD |
| CY2013Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
22200 | USD |
| cyrx |
Foreign Sales Revenue Net
ForeignSalesRevenueNet
|
321000 | USD | |
| cyrx |
Foreign Sales Revenue Net
ForeignSalesRevenueNet
|
589700 | USD | |
| CY2012Q4 | cyrx |
Foreign Sales Revenue Net
ForeignSalesRevenueNet
|
142000 | USD |
| CY2013Q4 | cyrx |
Foreign Sales Revenue Net
ForeignSalesRevenueNet
|
273000 | USD |
| cyrx |
Percentage Of Foreign Sales Revenue
PercentageOfForeignSalesRevenue
|
0.44 | pure | |
| cyrx |
Percentage Of Foreign Sales Revenue
PercentageOfForeignSalesRevenue
|
0.32 | pure | |
| CY2012Q4 | cyrx |
Percentage Of Foreign Sales Revenue
PercentageOfForeignSalesRevenue
|
0.46 | pure |
| CY2013Q4 | cyrx |
Percentage Of Foreign Sales Revenue
PercentageOfForeignSalesRevenue
|
0.36 | pure |
| us-gaap |
Concentration Risk Percentage1
ConcentrationRiskPercentage1
|
0.1 | pure | |
| us-gaap |
Concentration Risk Percentage1
ConcentrationRiskPercentage1
|
0.31 | pure | |
| CY2012Q4 | us-gaap |
Concentration Risk Percentage1
ConcentrationRiskPercentage1
|
0.1 | pure |
| CY2013Q4 | us-gaap |
Concentration Risk Percentage1
ConcentrationRiskPercentage1
|
0.32 | pure |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
37828000 | shares | |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
47425000 | shares | |
| CY2012Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
37830000 | shares |
| CY2013Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
65130000 | shares |
| CY2013Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
28533 | USD |
| CY2013Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
30008 | USD |
| CY2013Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
10679 | USD |
| CY2013Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
0 | USD |
| us-gaap |
Depreciation
Depreciation
|
222729 | USD | |
| us-gaap |
Depreciation
Depreciation
|
175020 | USD | |
| CY2012Q4 | us-gaap |
Depreciation
Depreciation
|
63183 | USD |
| CY2013Q4 | us-gaap |
Depreciation
Depreciation
|
51476 | USD |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
84533 | USD | |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
83169 | USD | |
| CY2012Q4 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
27148 | USD |
| CY2013Q4 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
27723 | USD |
| CY2013Q4 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
41890 | USD |
| CY2013Q1 | cyrx |
Property Plant And Equipment Percentage Of Specific Assets
PropertyPlantAndEquipmentPercentageOfSpecificAssets
|
0.87 | pure |
| CY2013Q4 | cyrx |
Property Plant And Equipment Percentage Of Specific Assets
PropertyPlantAndEquipmentPercentageOfSpecificAssets
|
0.89 | pure |
| CY2013Q1 | us-gaap |
Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
|
651500 | USD |
| CY2013Q4 | us-gaap |
Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
|
579500 | USD |
| CY2006Q2 | cyrx |
Aggregate Monthly Principal Payment
AggregateMonthlyPrincipalPayment
|
2500 | USD |
| CY2013Q4 | us-gaap |
Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
|
13713767 | USD |
| cyrx |
Debt Conversion Converted Instrument Units Description
DebtConversionConvertedInstrumentUnitsDescription
|
Each Unit consisting of (i) one share of common stock of the Company (“Common Stock”) and (ii) one warrant to purchase one share of Common Stock at an exercise price of $0.37 per share. | ||
| CY2013 | us-gaap |
Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
|
0 | pure |
| us-gaap |
Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
|
0 | pure | |
| us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
27712 | USD | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
1.24 | pure | |
| CY2013Q4 | cyrx |
Aggregate Principal Payment
AggregatePrincipalPayment
|
8000 | USD |
| cyrx |
Maturity Period Of Remaining Unpaid Principal And Accrued Interest
MaturityPeriodOfRemainingUnpaidPrincipalAndAccruedInterest
|
2015-03-01 | ||
| us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
32202 | USD | |
| us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
27882 | USD | |
| CY2012Q4 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
10364 | USD |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
1.27 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0222 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0184 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0063 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0019 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure | |
| CY2013Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5408597 | shares |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
7648272 | shares | |
| us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
650000 | shares | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
70000 | shares | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
12336869 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
5202530 | shares |
| CY2013Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.93 | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.27 | ||
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.20 | ||
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
7.71 | ||
| us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
20845 | USD | |
| CY2013Q4 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
1196 | USD |
| us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
156000 | USD | |
| us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
140800 | USD | |
| cyrx |
Class Of Warrant Or Right Expense
ClassOfWarrantOrRightExpense
|
837 | USD | |
| CY2012Q4 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
49000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
39300 | USD |
| cyrx |
Minimum Amount Of Additional Compensation
MinimumAmountOfAdditionalCompensation
|
2000000 | USD | |
| cyrx |
Additional Information For Additional Compensation
AdditionalInformationForAdditionalCompensation
|
additional compensation shall not be less than $2 million plus two times the “cost of work” | ||
| cyrx |
Period For Completion Of Agreement
PeriodForCompletionOfAgreement
|
P1Y | ||
| us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
8843 | USD | |
| CY2012Q4 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | USD |
| us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
3091 | USD | |
| us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
199170 | USD | |
| CY2012Q4 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
0 | USD |
| cyrx |
Automatically Renewal Period
AutomaticallyRenewalPeriod
|
P1Y | ||
| cyrx |
Consulting Service Fee
ConsultingServiceFee
|
287816 | USD | |
| cyrx |
Consulting Service Fee
ConsultingServiceFee
|
319882 | USD | |
| CY2012Q4 | cyrx |
Consulting Service Fee
ConsultingServiceFee
|
91145 | USD |
| CY2013Q4 | cyrx |
Consulting Service Fee
ConsultingServiceFee
|
113431 | USD |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
1.66 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
1.4 | pure | |
| CY2013Q4 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
8934 | USD |
| CY2013Q1 | cyrx |
Accrued Interest Related Party
AccruedInterestRelatedParty
|
766164 | USD |
| CY2013Q4 | cyrx |
Accrued Interest Related Party
AccruedInterestRelatedParty
|
794046 | USD |
| us-gaap |
Related Party Transaction Rate
RelatedPartyTransactionRate
|
0.06 | pure | |
| CY2013Q4 | cyrx |
Debt Conversion Converted Instrument Units Issued
DebtConversionConvertedInstrumentUnitsIssued
|
20636011 | shares |
| CY2013Q4 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
0.20 | |
| CY2013Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
|
0.37 | |
| CY2013Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
|
0.49 | |
| CY2013Q4 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
0 | USD |
| CY2013Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
4059801 | USD |
| CY2013Q4 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
4127202 | USD |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.52 | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.83 | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y9M | ||
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P7Y10M17D | ||
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
607284 | USD |
| CY2013Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
286953 | USD |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
3939794 | shares | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.25 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.24 | ||
| CY2011Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2500000 | shares |
| CY2011Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2011Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
2500 | shares |
| CY2012Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
30000 | shares |
| CY2011Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
155844 | shares |
| CY2013Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
220500 | shares |
| dei |
Document Type
DocumentType
|
10-Q | ||
| us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
82800 | USD | |
| us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
0 | USD | |
| cyrx |
Class Of Warrant Or Right Expense
ClassOfWarrantOrRightExpense
|
280 | USD | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
2300000 | shares |
| CY2013Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
344827 | shares |
| CY2013Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7100000 | shares |
| CY2012Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
3000000 | shares |
| CY2012Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
3000000 | shares |
| cyrx |
Fair Value Warrant Issued
FairValueWarrantIssued
|
793857 | USD | |
| CY2012Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1549003 | USD |
| CY2013Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1256991 | USD |
| us-gaap |
Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
|
0 | USD | |
| us-gaap |
Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
|
13713767 | USD | |
| CY2012Q4 | us-gaap |
Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
|
0 | USD |
| us-gaap |
Operating Expenses
OperatingExpenses
|
4097618 | USD | |
| CY2012Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
1487361 | USD |
| CY2013Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
1424052 | USD |
| CY2013Q4 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
757327 | USD |
| us-gaap |
Cost Of Revenue
CostOfRevenue
|
1066853 | USD | |
| us-gaap |
Cost Of Revenue
CostOfRevenue
|
1531312 | USD | |
| CY2012Q4 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
368795 | USD |
| CY2013Q4 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
590266 | USD |
| us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
4127202 | USD | |
| CY2013Q4 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
70000 | USD |
| cyrx |
Debt Conversion Converted Instrument Units Issued
DebtConversionConvertedInstrumentUnitsIssued
|
20636011 | shares | |
| CY2013Q4 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
0.20 | |
| CY2013Q3 | us-gaap |
Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
|
92171 | USD |
| CY2013Q2 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
500000 | shares |
| CY2013Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.20 | |
| CY2013Q2 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
100000 | USD |
| cyrx |
Commission On Notes Issued Percentage
CommissionOnNotesIssuedPercentage
|
0.09 | pure | |
| CY2013Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2013Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2013Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2500000 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2500000 | shares |
| CY2013Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2013Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2013Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2013Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
59246639 | shares |
| CY2013Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
37760628 | shares |
| us-gaap |
Sales Revenue Net
SalesRevenueNet
|
732049 | USD | |
| us-gaap |
Sales Revenue Net
SalesRevenueNet
|
1825117 | USD | |
| CY2012Q4 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
307153 | USD |
| us-gaap |
Gross Profit
GrossProfit
|
-334804 | USD | |
| us-gaap |
Gross Profit
GrossProfit
|
293805 | USD | |
| CY2012Q4 | us-gaap |
Gross Profit
GrossProfit
|
-61642 | USD |
| CY2013Q4 | us-gaap |
Gross Profit
GrossProfit
|
167061 | USD |
| us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
4003544 | USD | |
| us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3768049 | USD | |
| CY2012Q4 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1392937 | USD |
| CY2013Q4 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1305562 | USD |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
305031 | USD | |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
329569 | USD | |
| CY2012Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
94424 | USD |
| CY2013Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
118490 | USD |
| us-gaap |
Operating Expenses
OperatingExpenses
|
4308575 | USD | |
| us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
128275 | USD | |
| us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
358489 | USD | |
| us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
72000 | USD | |
| us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
72000 | USD | |
| us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
0 | USD | |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4643379 | USD | |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3803813 | USD | |
| CY2012Q4 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
-6112 | USD |
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-14319703 | USD | |
| CY2012Q4 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-18008 | USD |
| CY2013Q4 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-583340 | USD |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-18123516 | USD | |
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.12 | ||
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.40 | ||
| CY2012Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.04 | |
| CY2013Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.03 | |
| us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
37760628 | shares | |
| CY2013Q4 | us-gaap |
Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
|
552750 | USD |
| us-gaap |
Interest Expense
InterestExpense
|
48255 | USD | |
| us-gaap |
Interest Expense
InterestExpense
|
626781 | USD | |
| us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
45342320 | shares | |
| CY2012Q4 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
37760628 | shares |
| CY2013Q4 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
58995821 | shares |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
307262 | USD | |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
258189 | USD | |
| us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
540648 | USD | |
| cyrx |
Fair Value Of Stock Options And Warrants Issued To Consultants Employees And Directors
FairValueOfStockOptionsAndWarrantsIssuedToConsultantsEmployeesAndDirectors
|
-488818 | USD | |
| cyrx |
Fair Value Of Stock Options And Warrants Issued To Consultants Employees And Directors
FairValueOfStockOptionsAndWarrantsIssuedToConsultantsEmployeesAndDirectors
|
-509966 | USD | |
| us-gaap |
Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
|
27712 | USD | |
| us-gaap |
Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
|
20845 | USD | |
| us-gaap |
Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
|
-6382 | USD | |
| us-gaap |
Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
|
-5884 | USD | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
55013 | USD | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
418590 | USD | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
3705 | USD | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-9204 | USD | |
| us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-8940 | USD | |
| us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
22898 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
301425 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
129415 | USD | |
| CY2012Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-1567011 | USD |
| CY2013Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-1840331 | USD |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1600 | USD | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD | |
| CY2012Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2013Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-4665522 | USD | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-18123516 | USD | |
| CY2012Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1567011 | USD |
| CY2013Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1840331 | USD |
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-67531 | USD | |
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
174006 | USD | |
| us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
19625 | USD | |
| us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
85364 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3678188 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3159406 | USD | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
71165 | USD | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
139541 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-71165 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-139541 | USD | |
| us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
0 | USD | |
| us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
3206301 | USD | |
| dei |
Amendment Flag
AmendmentFlag
|
false | ||
| dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-12-31 | ||
| dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | ||
| dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
| dei |
Trading Symbol
TradingSymbol
|
CYRX | ||
| CY2014Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
59446639 | shares |
| us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
1600 | USD | |
| dei |
Entity Registrant Name
EntityRegistrantName
|
Cryoport, Inc. | ||
| cyrx |
Release Of Restricted Cash For Repayment Of Convertible Debentures Payable
ReleaseOfRestrictedCashForRepaymentOfConvertibleDebenturesPayable
|
0 | USD | |
| cyrx |
Release Of Restricted Cash For Repayment Of Convertible Debentures Payable
ReleaseOfRestrictedCashForRepaymentOfConvertibleDebenturesPayable
|
251368 | USD | |
| cyrx |
Offering Costs In Connection With Equity Financing Included In Accounts Payable
OfferingCostsInConnectionWithEquityFinancingIncludedInAccountsPayable
|
0 | USD | |
| cyrx |
Offering Costs In Connection With Equity Financing Included In Accounts Payable
OfferingCostsInConnectionWithEquityFinancingIncludedInAccountsPayable
|
53747 | USD | |
| cyrx |
Debt Conversion Converted Instrument Amount Warrant Issued
DebtConversionConvertedInstrumentAmountWarrantIssued
|
255452 | USD | |
| cyrx |
Debt Conversion Converted Instrument Amount Warrant Issued
DebtConversionConvertedInstrumentAmountWarrantIssued
|
0 | USD | |
| us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
0 | USD | |
| CY2013Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
220500 | shares |
| CY2013Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
56282 | USD |
| CY2013Q4 | cyrx |
Warrants Exercisable Date
WarrantsExercisableDate
|
2014-05-31 | |
| dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001124524 | ||
| dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--03-31 | ||
| dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | ||
| us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
180001 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2955813 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-283075 | USD | |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-343134 | USD | |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-4032428 | USD | |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
585107 | USD |
| CY2012Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4617535 | USD |
| us-gaap |
Interest Paid
InterestPaid
|
0 | USD | |
| us-gaap |
Interest Paid
InterestPaid
|
15676 | USD | |
| us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD | |
| us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P5Y | ||
| us-gaap |
Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
|
0 | USD | |
| CY2013 | us-gaap |
Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
|
0 | USD |
| CY2012Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
|
0.50 | |
| CY2011Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
|
0.77 | |
| CY2011Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
|
1.38 | |
| cyrx |
Percentage Of Conversion Price Of Stock Equal To Volume Weighted Average Price
PercentageOfConversionPriceOfStockEqualToVolumeWeightedAveragePrice
|
0.7 | pure | |
| cyrx |
Percentage Of Warrants Exercise Equal To Volume Weighted Average Price
PercentageOfWarrantsExerciseEqualToVolumeWeightedAveragePrice
|
1.1 | pure | |
| CY2013Q4 | invest |
Investment Warrants Expiration Date
InvestmentWarrantsExpirationDate
|
2018-12-31 | |
| cyrx |
Debt Conversion Non Cash Expense
DebtConversionNonCashExpense
|
13700000 | USD |
